e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Experimental approaches in animals and modelling in humans
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity
A. G. L. S. D. Silva, D. M. Laks, C. B. Magalhaes, P. P. Pereira-Junior, J. H. M. Nascimento, A. P. C. Davel, L. V. Rossoni, C. M. Takiya, D. S. Faffe, W. A. Zin (Rio de Janeiro, São Paulo, Brazil)
Source:
Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Session:
Experimental approaches in animals and modelling in humans
Session type:
E-Communication Session
Number:
4727
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. G. L. S. D. Silva, D. M. Laks, C. B. Magalhaes, P. P. Pereira-Junior, J. H. M. Nascimento, A. P. C. Davel, L. V. Rossoni, C. M. Takiya, D. S. Faffe, W. A. Zin (Rio de Janeiro, São Paulo, Brazil). Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity. Eur Respir J 2009; 34: Suppl. 53, 4727
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Rosiglitazone, an agonist of PPARγ, reduces acute lung injury in endotoxemic rats
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
Genistein rescues pulmonary hypertension and attenuates abnormal vasoconstriction in rats lungs
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Clenbuterol antagonize the effect of chronic administration of steroid respiratory muscle in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 496s
Year: 2002
Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008
Theophylline increases muscle sympathetic activity in patients with congestive heart failure
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003
Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Paraquat-induced lung injury in rat presents altered pressor chemoreflex response probably due to vascular dysfunction
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Hyperinflation associated with COPD is associated with impaired cardiac function and spontaneous baroreceptor sensitivity
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Creatine supplementation attenuates systemic and pulmonary effects of acute lung injury induced by pulmonary ischemia-reperfusion in rats
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
The hsp90 inhibitor, 17-AAG prevents and reverses the increases in lung calcineurin expression and activity associated with monocrotaline-induced right ventricular hypertrophy
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 334s
Year: 2004
The PPAR-β/δ agonist GW0742 reverses right venticular hypertrophy in a chronically hypoxic rat model of pulmonary hypertension
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Aminophylline increases respiratory muscle activity during hypercapnia in humans
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Dexamethasone reduces lung inflammation induced by alveolar stretch in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
α
1
-adrenoceptor antagonism does not modify the pulmonary vasoconstrictor effect of dexfenfluramine in the rat
Source: Eur Respir J 2001; 18: Suppl. 33, 491s
Year: 2001
Improvement of exercise capacity due to beta blocker treatment in the model of MCT induced pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept